According to Satya Nadella, the launch of DxGPT marks a significant advancement in the use of AI for diagnosing rare diseases. The tool is now live and demonstrates the potential of artificial intelligence to make substantial improvements in healthcare (source: Satya Nadella's Twitter). This development is crucial for traders and investors focusing on AI-driven healthcare solutions, as it could indicate a growing market trend.